Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Corbus Pharma (NQ: CRBP )

1.390 USD -0.020 (-1.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Corbus Pharma

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Thinking about buying stock in Aravive, Marin Software, Staffing 360 Solutions, Corbus Pharmaceuticals, or Globalstar?
InvestorsObserver issues critical PriceWatch Alerts for ARAV, MRIN, STAF, CRBP, and GSAT. 
From PR Newswire
Corbus Pharmaceuticals Announces Topline Results from DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
From GlobeNewswire News Releases
Thinking about buying stock in AMC, Corbus Pharmaceuticals, Syros Pharmaceuticals, Canaan, or Lineage Cell Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for AMC, CRBP, SYRS, CAN, and LCTX. 
From PR Newswire
Corbus Pharmaceuticals Licenses Two Integrin Targeting mAbs Further Expanding Pipeline into Cancer and Fibrotic Diseases
From GlobeNewswire News Releases
Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2021 Virtual Congress
From GlobeNewswire News Releases
CORBUS PHARMACEUTICALS ANNOUNCES ADJOURNMENT OF ANNUAL MEETING
From GlobeNewswire News Releases
Corbus Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Updates
From GlobeNewswire News Releases
Corbus Pharmaceuticals to Present at Three Upcoming Investor Conferences
From GlobeNewswire News Releases
Corbus Pharmaceuticals Announces Completion of Enrollment in NIH-Sponsored Phase 2 Study of Lenabasum for Treatment of Systemic Lupus Erythematosus (SLE)
From GlobeNewswire News Releases
Corbus Pharmaceuticals Reports Last Subject Visit in DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
From GlobeNewswire News Releases
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial Results
From GlobeNewswire News Releases
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences
From GlobeNewswire News Releases
Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2020 Results on March 15, 2021
From GlobeNewswire News Releases
4 Hot Small Cap Stocks: Corbus Pharmaceuticals (NASDAQ: CRBP) Medical Marijuana (OTC US: MJNA) Microvision (NASDAQ: MVIS) and Global Battery Metals (OTC US: REZZF)
Tags Stock Reports ALPP IBIO
From OTC
Thinking about buying stock in AMC Entertainment, Nokia, Corbus Pharmaceuticals, GameStop, or Microvision?
InvestorsObserver issues critical PriceWatch Alerts for AMC, NOK, CRBP, GME, and MVIS. 
From PR Newswire
Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human Diseases
From GlobeNewswire News Releases
The Little-Known Tech That Could Transform Healthcare
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
The Little-Known Tech That Could Transform Healthcare
FN Media Group Presents Safehaven.com Market Commentary 
From PR Newswire
Thinking about buying stock in Nantkwest, RealPage, Aerojet Rocketdyne, AIM ImmunoTech, or Corbus Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for NK, RP, AJRD, AIM, and CRBP. 
From PR Newswire
Thinking about buying stock in Titan Pharmaceuticals, Moderna, Moleculin Biotech, Corbus Pharmaceuticals, or Altimmune?
InvestorsObserver issues critical PriceWatch Alerts for TTNP, MRNA, MBRX, CRBP, and ALT. 
From PR Newswire
Corbus Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
From GlobeNewswire News Releases
Corbus Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Updates
From GlobeNewswire News Releases
Corbus Pharmaceuticals Presents Additional Data from RESOLVE-1 Study in Systemic Sclerosis
From GlobeNewswire News Releases
Corbus Pharmaceuticals to Report Third Quarter Results on November 10, 2020
From GlobeNewswire News Releases
Corbus Pharmaceuticals Announces Presentation of Data from its Phase 2b Study in Cystic Fibrosis at NACFC 2020
From GlobeNewswire News Releases
Corbus Pharmaceuticals Announces Three Lenabasum Abstracts to be Presented at ACR Convergence 2020
From GlobeNewswire News Releases
Corbus Pharmaceuticals Announces Corporate Restructuring and Pipeline Portfolio Updates
From GlobeNewswire News Releases
Corbus Pharmaceuticals Announces Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis Did Not Meet Primary Endpoint
From GlobeNewswire News Releases
Corbus Pharmaceuticals Announces Topline Results from RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
From GlobeNewswire News Releases
Thinking about trading options or stock in Qualcomm, Yandex, Advanced Micro Devices, Estee Lauder, or Corbus Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for QCOM, YNDX, AMD, EL, and CRBP. 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.